(Q33837723)

29 July 2017

1 reference

title

Recent advances in the treatment of severe melioidosis (English)

1 reference

29 July 2017

0 references

Chaowagul W

1

1 reference

29 July 2017

publication date

1 February 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

74

1 reference

29 July 2017

issue

2-3

1 reference

29 July 2017

page(s)

133-137

1 reference

In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Oral fluoroquinolones for maintenance treatment of melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Melioidosis: the tip of the iceberg?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Interactions in vitro between agents used to treat melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Comparison of imipenem and ceftazidime as therapy for severe melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Amoxycillin-clavulanic acid treatment of melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Clinical and laboratory studies of malaria and melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Halving of mortality of severe melioidosis by ceftazidime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900062-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-706X(99)00062-5

1 reference

29 July 2017

1 reference